Thermo Fisher Scientific Intelligence Profile

thermofisher.comLast reviewed: October 20, 2026Research coverage: 94%

Overall data confidence:Unknown

Identity confidence

High

9 of 10 identity fields independently documented

Corporate continuity

Continuous — thermofisher.com has operated as the company's primary corporate and commerce site since 2006; the Fisher Scientific channel operates at fishersci.com

Based on domain history and corporate record fields

Regulatory exposure

None identified

Derived from published risk flags

Evidence integrity

High

6 of 7 testing fields documented

Transaction transparency

High

5 of 5 commercial fields documented

Change activity

None tracked

0 change events tracked

Research Incomplete

Research coverage for this vendor is 94%. Our research on Thermo Fisher Scientific remains incomplete — what we have verified so far is published below, and research is continuing.

Still to research:

Public summary reviewed

Overview#

Thermo Fisher Scientific Inc. (Delaware, incorporated 1956; HQ 168 Third Avenue, Waltham, MA; NYSE: TMO) is one of the world's largest life-science suppliers. Its peptide offer is a custom synthesis service (2–110 aa, MS/HPLC QC documentation delivered per order) plus catalog reagents, under brands including Thermo Scientific, Fisher Scientific, Alfa Aesar and Acros Organics — this record covers the family. Identity is fully verified from SEC-grade sources. Regulatory footprint: two historical FTC merger consent orders (antitrust conditions, 2006 and 2014); FDA Class II recalls confined to diagnostics/microbiology subsidiaries — no peptide recalls and no FDA warning letter found; and a $25,000 civil Controlled Substances Act recordkeeping settlement by a chemicals subsidiary (self-disclosed). The principal open evidence item is the August 2026 independent report of manipulated antibody validation images (allegation-level; company reviewing) — it does not involve peptides. Registered agent and test recency are Unknown. No High/Critical findings for the peptide business.

Company Identity#

Vendor Brand NameThermo Fisher Scientific

HighSource: BCC Research company profile — Thermo Fisher Scientific Inc.

Primary Website Domainthermofisher.com

ModerateSource: Thermo Fisher Scientific — official website (intake domain confirmation)

Legal Entity NameThermo Fisher Scientific Inc.

HighSource: Thermo Fisher Scientific Form 10-K text (SEC filing mirror)

State of RegistrationDelaware

HighSource: Thermo Fisher Scientific Form 10-K text (SEC filing mirror)

Entity StatusActive — Delaware corporation; SEC registrant; NYSE: TMO

HighSource: Thermo Fisher Scientific Form 10-K text (SEC filing mirror)

Incorporation / Formation Date1956

HighSource: Thermo Fisher Scientific Form 10-K text (SEC filing mirror)

Named Principals / ManagersMarc N. Casper — Chairman and Chief Executive Officer (CEO since October 2009; Chairman since February 2020; also served as President from 2009 until March 2026)

HighSource: Thermo Fisher Scientific investor relations — Board of Directors: Marc N. Casper

Registered AgentNot independently verified

UnknownSource: Thermo Fisher Scientific Form 10-K text (SEC filing mirror)

Operating Address168 Third Avenue, Waltham, MA 02451, USA (principal executive offices)

HighSource: Thermo Fisher Scientific investor relations — Board of Directors: Marc N. Casper

Address ConsistencyConsistent — 168 Third Avenue, Waltham, MA appears across SEC filings and company investor pages; the earlier 81 Wyman Street address is also in Waltham and reflects a prior headquarters, not a conflict

ModerateSource: Thermo Fisher Scientific investor relations — Board of Directors: Marc N. Casper

Domain and Digital Identity#

Domain Registration Date2006-05-08

HighSource: Verisign RDAP — thermofisher.com

Domain Ownership / Registrar Change HistoryRegistrar: MarkMonitor Inc.; RDAP record last changed 2026-04-06. Registrant identity is redacted in RDAP, so ownership is evidenced indirectly (site operation and investor pages). Domain creation in 2006 coincides with the merger that formed the company; no transfer or impersonation signals found.

ModerateSource: Verisign RDAP — thermofisher.com

Website ContinuityContinuous — thermofisher.com has operated as the company's primary corporate and commerce site since 2006; the Fisher Scientific channel operates at fishersci.com

ModerateSource: Verisign RDAP — thermofisher.com

Contact Channel IntegrityOfficial channels published on company pages: corporate phone +1-781-622-1000 and investorrelations@thermofisher.com (investor relations); customer support via thermofisher.com and fishersci.com. No conflicting third-party contact details identified.

ModerateSource: Thermo Fisher Scientific investor relations — Board of Directors: Marc N. Casper

Regulatory and Legal History#

FDA Warning Letter HistoryNo Record Found in the defined search

ModerateSource: Defined web search of fda.gov warning letters — no letter naming Thermo Fisher Scientific

FDA Recall / Safety Action HistoryFDA Class II recalls exist against Thermo Fisher subsidiaries in diagnostics/microbiology lines — none involve peptides: Remel Inc. Strep Selective II Agar (Recall Z-2224-2025, initiated 2025-07-11, Listeria contamination, status Open); Remel Sensititre broth medium (Z-1947-2025); Thermo Fisher Scientific (Asheville) LLC laboratory water bath (Z-1868-2019); Microgenics Corp. MAS Bilirubin control (Z-1563-2013).

HighSource: FDA recall record — Remel Inc. Strep Selective II Agar, Recall Z-2224-2025

FDA Import Alert / Detention ExposureNo Record Found in the defined search

ModerateSource: Defined web search — FDA import alerts naming Thermo Fisher Scientific

FTC Enforcement HistoryTwo historical FTC merger consent orders (antitrust merger conditions — not product or consumer-protection actions): (1) 2006 — Thermo Electron Corp./Fisher Scientific, FTC Matter No. 0610187, requiring divestiture of Fisher's Genevac centrifugal vacuum evaporator business; (2) 2014 — Life Technologies acquisition ($13.6B), Docket No. C-4431, requiring divestiture of the Dharmacon siRNA reagents and HyClone cell culture media/sera businesses to GE Healthcare.

ModerateSource: FTC complaint — Thermo Fisher Scientific / Life Technologies (CCH mirror of FTC filing)

State Regulatory / Attorney General ActionsNo Record Found in the defined search

ModerateSource: Defined web search — no record naming the vendor found

Relevant Civil LitigationGene Tox Worldwide LLC d/b/a TruGenX v. Thermo Fisher Scientific Inc., No. 2:21-cv-02854 (D.N.J.) — breach of contract/warranty, fraud and negligent-misrepresentation claims concerning COVID-19 testing equipment (diagnostics, not peptides). As a large public company the vendor is party to routine commercial and employment litigation; no peptide-related litigation was identified in the defined search.

ModerateSource: Law360 reprint — Gene Tox Worldwide LLC d/b/a TruGenX v. Thermo Fisher Scientific Inc., No. 2:21-cv-02854 (D.N.J.)

Criminal / Injunctive ProceedingsNo criminal proceedings found. One federal civil regulatory settlement: Thermo Fisher Scientific Chemicals, Inc. (subsidiary) agreed to pay $25,000 to resolve Controlled Substances Act recordkeeping allegations — failure to file export declarations for listed chemicals, distribution to a location lacking DEA registration, and purchases from suppliers lacking registration; the violations were self-disclosed to the DEA (U.S. Attorney's Office, District of Massachusetts). Civil settlement; not peptide-related.

HighSource: U.S. Attorney's Office, District of Massachusetts (DOJ) — Thermo Fisher Scientific Chemicals CSA settlement

Testing and COA Evidence#

Public COA AvailabilityNo public per-lot COA library exists for the peptide service. The vendor's Custom Peptide Synthesis brochure states analytical documentation accompanies orders: mass spectrometry (MS) for crude peptides, and MS + HPLC for purified grades.

ModerateSource: Thermo Fisher — Custom Peptide Synthesis brochure

Batch / Lot SpecificityAnalytical data (MS; MS + HPLC for purified grades) is generated per synthesis order/lot and delivered with the order; results are not published in a public lot-lookup library.

ModerateSource: Thermo Fisher — Custom Peptide Synthesis brochure

Independent Laboratory IdentityIn-house vendor QC laboratories; no independent third-party testing laboratory is named for the custom peptide service.

ModerateSource: Thermo Fisher — Custom Peptide Synthesis brochure

COA Verification StatusNot independently verifiable — no public COA repository or third-party verification channel exists for the peptide service; documentation is issued by the vendor with each order.

ModerateSource: Thermo Fisher — Custom Peptide Synthesis brochure

Test RecencyNot independently verified

UnknownSource: Thermo Fisher — Custom Peptide Synthesis brochure

Testing CoverageCustom peptides 2–110 amino acids, 1 mg to 1 kg+, crude to >98% purity grades; MS quality control on the crude grade and MS + HPLC on other grades; extensive modifications, labels and conjugations; PEPotec peptide libraries.

ModerateSource: Thermo Fisher — Custom Peptide Synthesis brochure

Evidence ConsistencyOpen evidence item (antibodies — not peptides): an August 2026 independent research-integrity report by Reese Richardson documented duplicated/manipulated validation-image backgrounds in the catalogs of 15 vendors, including Thermo Fisher Scientific (a May 2026 report covered Thermo Fisher specifically; ~19,000 images cataloged across the 15). Thermo Fisher responded that it takes validation seriously, was reviewing website Western blot images including third-party-provided ones, had found no evidence of impact to antibody performance, and by 14 September 2026 had removed quotation marks from citation summaries. Independent allegation — not a regulatory finding.

ModerateSource: C&EN — New report suggests widespread image manipulation in antibody market (Aug 2026)

Payment, Refund and Shipping#

Accepted Payment MethodsAccount/invoice terms — payment net cash within 30 days per Thermo Fisher's terms and conditions of sale; web orders are placed through the Fisher Scientific store (account and card payment at checkout).

ModerateSource: Thermo Fisher Scientific Terms and Conditions of Sale (2022-04-15) — net 30 days

Refund / Return PolicyFisherbrand Guarantee (fishersci.com): Fisherbrand products are returnable for any reason within 30 days for full credit excluding freight; exclusions include refrigerated products, opened reagents/chemicals, and equipment priced $1,000 or more. Fisher Scientific Canada terms: returns only with consent, 20% restocking charge, no returns of temperature-sensitive products. Custom products (including custom-synthesized peptides) are generally excluded from return under standard terms.

ModerateSource: Fisher Scientific — Refund Policy / Fisherbrand Guarantee

Shipping & Fulfillment RepresentationsDelivery terms are set in the published terms of sale and confirmed at order through the Fisher Scientific distribution network; no peptide-specific shipping representations are published.

LowSource: Fisher Scientific — Refund Policy / Fisherbrand Guarantee

Terms / Policy StabilityTerms of sale are published and versioned (e.g., Thermo Fisher Scientific Terms and Conditions of Sale dated 2022-04-15); no abrupt policy changes observed in this intake pass.

LowSource: Thermo Fisher Scientific Terms and Conditions of Sale (2022-04-15) — net 30 days

Customer Complaint PatternScattered consumer-review complaints about delayed orders and unresponsive support for thermofisher.com orders on review aggregators; no BBB/AG fraud pattern identified. The dominant 2026 public criticism concerns antibody validation imagery (see evidence_consistency), not fulfillment.

ModerateSource: AskMeOffers — thermofisher.com user reviews

Material Changes#

No material changes recorded.

Sources#

FDA recall record — Remel Inc. Strep Selective II Agar, Recall Z-2224-2025Tier 1 · AuthoritativeRegulatory SearchAuthoritative

Retrieved: October 20, 2026